Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline Moiety
Tóm tắt
Identification of the novel (E)-N′-((2-chloro-7-methoxyquinolin-3-yl)methylene)-3-(phenylthio)propanehydrazide scaffold 18 has led to the development of a new series of biologically active hydrazide compounds. The parent compound 18 and new quinoline derivatives 19–26 were prepared from the corresponding quinoline hydrazones and substituted carboxylic acids using EDC-mediated peptide coupling reactions. Further modification of the parent compound 18 was achieved by replacement of the quinoline moiety with other aromatic systems. All the newly synthesized compounds were evaluated for their anti-cancer activity against the SH-SY5Y and Kelly neuroblastoma cell lines, as well as the MDA-MB-231 and MCF-7 breast adenocarcinoma cell lines. Analogues 19 and 22 significantly reduced the cell viability of neuroblastoma cancer cells with micromolar potency and significant selectivity over normal cells. The quinoline hydrazide 22 also induced G1 cell cycle arrest, as well as upregulation of the p27kip1 cell cycle regulating protein.
Từ khóa
Tài liệu tham khảo
Lautz, T.B., Jie, C., Clark, S., Naiditch, J.A., Jafari, N., Qiu, Y.Y., Zheng, X., Chu, F., and Madonna, M.B. (2012). The effect of vorinostat on the development of resistance to doxorubicin in neuroblastoma. PLoS ONE, 7.
Steven, 2012, Mechanisms of Resistance to Histone Deacetylase Inhibitors, Advances in Cancer Research, Volume 116, 39, 10.1016/B978-0-12-394387-3.00002-1
Richon, 2006, Cancer biology: Mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor, Br. J. Cancer, 95, 2, 10.1038/sj.bjc.6603463
Basu, 2011, Pre-treatment with anti-oxidants sensitizes oxidatively stressed human cancer cells to growth inhibitory effect of suberoylanilide hydroxamic acid (SAHA), Cancer Chemother. Pharmacol., 67, 705, 10.1007/s00280-010-1364-3
Mann, 2007, Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma, Clin. Cancer Res., 13, 2318, 10.1158/1078-0432.CCR-06-2672
Kelly, 2005, Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer, J. Clin. Oncol., 23, 3923, 10.1200/JCO.2005.14.167
Rundall, 2005, Combined histone deacetylase and NF-κB inhibition sensitizes non-small cell lung cancer to cell death, Surgery, 138, 360, 10.1016/j.surg.2005.06.016
Sonnemann, 2005, Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines, Investig. New Drug, 23, 99, 10.1007/s10637-005-5854-9
Denlinger, 2004, Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species, J Thorac. Cardiov. Sur., 128, 740, 10.1016/j.jtcvs.2004.07.010
Arndt, G. Personal Communication.
Chen, 2006, Synthesis and antiproliferative evaluation of certain 4-anilino-8-methoxy-2-phenylquinoline and 4-anilino-8-hydroxy-2-phenylquinoline derivatives, Bioorg. Med. Chem., 14, 3098, 10.1016/j.bmc.2005.12.017
Chen, 2006, Synthesis, cytotoxicity, and anti-inflammatory evaluation of 2-(furan-2-yl)-4-(phenoxy)quinoline derivatives, Bioorg. Med. Chem., 14, 4373, 10.1016/j.bmc.2006.02.039
Feng, 2013, Inhibition of melanoma development in the Nras(Q61K): Ink4a(−/−) mouse model by the small molecule BI-69A11, Pigm. Cell Melanoma Res., 26, 136, 10.1111/pcmr.12033
Gholap, 2007, Synthesis and evaluation of antifungal properties of a series of the novel 2-amino-5-oxo-4-phenyl-5,6,7,8-tetrahydroquinoline-3-carbonitrile and its analogues, Bioorg. Med. Chem., 15, 6705, 10.1016/j.bmc.2007.08.009
Krafts, 2012, From methylene blue to chloroquine: A brief review of the development of an antimalarial therapy, Parasitol. Res., 111, 1, 10.1007/s00436-012-2886-x
Sanchez, 1988, Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids, J. Med. Chem., 31, 983, 10.1021/jm00400a016
Adsule, 2006, Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells, J. Med. Chem., 49, 7242, 10.1021/jm060712l
Nakamura, 1999, Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells, Biochem. Bioph. Res. Co., 255, 618, 10.1006/bbrc.1999.0245
Reddy, 1993, Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen, Cancer Res., 53, 3914
Shi, 2008, Synthesis and anti-breast cancer activities of substituted quinolones, Bioorg. Med. Chem. Lett., 18, 3364, 10.1016/j.bmcl.2008.04.024
Wall, 1966, Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2, J. Am. Chem. Soc., 88, 3888, 10.1021/ja00968a057
Sawada, 1991, Synthesis and antitumor activity of 20(S)-camptothecin derivatives: Carbamate-linked, water-soluble derivaties of 7-ethyl-10-hydroxycamptothecin, Chem. Pharm. Bull., 39, 1446, 10.1248/cpb.39.1446
Cortes, 2011, Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib, Blood, 118, 4567, 10.1182/blood-2011-05-355594
Cortes, 2012, Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial, J. Clin. Oncol., 30, 3486, 10.1200/JCO.2011.38.7522
Ajani, 2010, Microwave-assisted synthesis and antimicrobial activity of 2-quinoxalinone-3-hydrazone derivatives, Bioorg. Med. Chem., 18, 214, 10.1016/j.bmc.2009.10.064
Melnyk, 2006, Design, synthesis and in vitro antimalarial activity of an acylhydrazone library, Bioorg. Med. Chem. Lett., 16, 31, 10.1016/j.bmcl.2005.09.058
Zheng, 2009, Synthesis of novel substituted pyrazole-5-carbohydrazide hydrazone derivatives and discovery of a potent apoptosis inducer in A549 lung cancer cells, Bioorg. Med. Chem., 17, 1957, 10.1016/j.bmc.2009.01.037
Metwally, 2006, Hydrazones of 2-aryl-quinoline-4-carboxylic acid hydrazides: Synthesis and preliminary evaluation as antimicrobial agents, Bioorg. Med. Chem., 14, 8675, 10.1016/j.bmc.2006.08.022
Eswaran, 2010, Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents, Bioorg. Med. Chem. Lett., 20, 1040, 10.1016/j.bmcl.2009.12.045
Nayyar, 2007, Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines, Bioorg. Med. Chem., 15, 626, 10.1016/j.bmc.2006.10.064
Thomas, 2011, Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as anti-tubercular agents, Eur. J. Med. Chem., 46, 5283, 10.1016/j.ejmech.2011.07.033
Kumar, 2010, Synthesis and in vivo anti-convulsant evaluation of 2-chloroquinolinyl hydrazone derivatives, Acta. Pol. Pharmaceutica, 67, 567
Reddy, 2011, A “green” synthesis of N-(quinoline-3-ylmethylene)benzohydrazide derivatives and their cytotoxicity activities, J. Brazil. Chem. Soc., 22, 1742, 10.1590/S0103-50532011000900017
You, 2009, Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification, J. Med. Chem., 52, 5649, 10.1021/jm900469e
Weiss, 2008, Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors, J. Med. Chem., 51, 1668, 10.1021/jm701098w
Chen, 2013, Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy, Eur. J. Med. Chem., 62, 498, 10.1016/j.ejmech.2013.01.023
Moffat, 2010, Discovery of 2-(6-{[(6-fluoroquinolin-2-yl)methyl] amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a class I selective orally active histone deacetylase inhibitor, J. Med. Chem., 53, 8663, 10.1021/jm101177s
Shimizu, 2004, Orally active anti-proliferation agents: Novel diphenylamine derivatives as FGF-R2 auto-phosphorylation inhibitors, Bioorg. Med. Chem. Lett., 14, 875, 10.1016/j.bmcl.2003.12.019
Houssin, 2004, DNA Binding To Guide the Development of Tetrahydroindeno[1,2-b]pyrido[4,3,2-de]quinoline Derivatives as Cytotoxic Agents, J. Med. Chem., 47, 3665, 10.1021/jm0400193
Gasparotto, 2007, 3-substituted 7-phenyl-pyrroloquinolinones show potent cytotoxic activity in human cancer cell lines, J. Med. Chem., 50, 5509, 10.1021/jm070534b
Magedov, 2008, Structural Simplification of Bioactive Natural Products with Multicomponent Synthesis. 2. Antiproliferative and Antitubulin Activities of Pyrano[3,2-c]pyridones and Pyrano[3,2-c]quinolones, J. Med. Chem., 51, 2561, 10.1021/jm701499n
Tseng, 2013, Synthesis and antiproliferative evaluation of 3-phenylquinolinylchalcone derivatives against non-small cell lung cancers and breast cancers, Eur. J. Med. Chem., 59, 274, 10.1016/j.ejmech.2012.11.027
Tseng, 2012, Synthesis of 6-substituted-9-methoxy-11H-indeno[1,2-c]quinoline-11-one derivatives as potential anticancer agents, Bioorg. Med. Chem., 20, 4397, 10.1016/j.bmc.2012.05.035
Santosa, 2011, New betulinic acid derivatives induce potent and selective antiproliferative activity through cell cycle arrest at the S phase and caspase dependent apoptosis in human cancer cells, Biochimie, 93, 1065, 10.1016/j.biochi.2011.02.014
Szumilak, 2010, Synthesis and in vitro biological evaluation of new polyamine conjugates as potential anticancer drugs, Eur. J. Med. Chem., 45, 5744, 10.1016/j.ejmech.2010.09.032
Tseng, 2008, Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives, Bioorg. Med. Chem., 16, 3153, 10.1016/j.bmc.2007.12.028
Li, 2006, Synthesis and antiproliferative evaluation of certain pyrido[3,2-g]quinoline derivatives, Bioorg. Med. Chem., 14, 7370, 10.1016/j.bmc.2006.07.030
Zhou, 2000, Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1, J. Biol. Chem., 275, 35256, 10.1074/jbc.M003106200
Hengst, 1998, Inhibitors of the Cip/Kip family, Curr. Top. Microbiol. Immunol., 227, 25
Sherr, 1999, CDK inhibitors: positive and negative regulators of G1-phase progression, Genes Dev., 13, 1501, 10.1101/gad.13.12.1501
Slingerland, 2000, Regulation of the Cdk inhibitor p27 and its deregulation in cancer, J. Cell. Physiol., 183, 10, 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I
Chu, 2008, The Cdk inhibitor p27 in human cancer: Prognostic potential and relevance to anticancer therapy, Nat. Rev. Cancer, 8, 253, 10.1038/nrc2347
Catzavelos, 1997, Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer, Nat. Med., 3, 227, 10.1038/nm0297-227
Esposito, 1997, Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer, Cancer Res., 57, 3381
Loda, 1997, Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas, Nat. Med., 3, 231, 10.1038/nm0297-231
Masciullo, 1999, Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer, Cancer Res., 59, 3790
Porter, 2006, p27Kip1 and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy, J. Natl. Cancer Inst., 98, 1723, 10.1093/jnci/djj467
Tsihlias, 1998, Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma, Cancer Res., 58, 542
Barata, 2001, Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1), Blood, 98, 1524, 10.1182/blood.V98.5.1524
Harada, 2002, Over expression of p27Kip1 induces growth arrest and apoptosis in an oral cancer cell line, Oral Oncol., 38, 730, 10.1016/S1368-8375(02)00011-8
Jia, 2009, Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols, Bioorg. Med. Chem., 17, 4569, 10.1016/j.bmc.2009.05.001
Narine, 1981, A versatile new synthesis of quinolines and related fused pyridines, Part 5. The synthesis of 2-chloroquinoline-3-carbaldehydes, J. Chem. Soc. Perkin. Trans. 1, 1, 1520
French, 1926, Alpha-naphthylisocynate as a regaent for phenols and aliphatic amines, J. Am. Chem. Soc., 48, 1736, 10.1021/ja01417a041
2009, Synthesis and characterization of new Pt(II) and Pd(II) complexes with 2-quinolinecarboxaldehyde seleno-semicarbazone: Cytotoxic activity evaluation of Cd(II), Zn(II), Ni(II), Pt(II) and Pd(II) complexes with heteroaromatic, Eur. J. Med. Chem., 44, 1623, 10.1016/j.ejmech.2008.07.033
Ramachandran, 2012, Evaluation of DNA binding, antioxidant and cytotoxic activity of mononuclear Co(III) complexes of 2-oxo-1,2-dihydrobenzo[H]quinoline-3-carbaldehyde thiosemicarbazones, Eur. J. Med. Chem., 50, 405, 10.1016/j.ejmech.2012.02.026
Serda, 2012, Synthesis and characterization of quinoline-based thiosemicarbazones and correlation of cellular iron-binding efficacy to anti-tumor efficacy, Bioorg. Med. Chem. Lett., 22, 5527, 10.1016/j.bmcl.2012.07.030
CCDC 1436247 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: +44 1223 336033; E-mail: [email protected])
Cheung, 2003, Growth inhibitory retinoid effects after recruitment of retinoid X receptor β to the retinoic acid receptor β promoter, Int. J. Cancer, 105, 856, 10.1002/ijc.11153
Lai, 1989, A new synthetic approach to the rotenoid ring system, Tetrahedron, 45, 5895, 10.1016/S0040-4020(01)89116-X
Hardouin, 2007, Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase, J. Med. Chem., 50, 3359, 10.1021/jm061414r
Harvill, 1950, The Synthesis of 1,5-disubstituted tetrazoles, J. Org. Chem., 15, 662, 10.1021/jo01149a035
Horning, 1947, Aromatization Studies. V. Synthesis of alkylanilines from alkylcyclohexenones, J. Am. Chem. Soc., 69, 1907, 10.1021/ja01200a018
Shvo, 1998, Regioselective Catalytic dehydrogenation of aldehydes and ketones, J. Org. Chem., 63, 5640, 10.1021/jo980112x
Raghavendra, 2009, Synthesis of quinoline-based thieno-seleno-phenylquinazolinones, Phosphorus Sulfur., 184, 460, 10.1080/10426500802176945
Doboszewski, 2008, Carbohydrate chiral-pool approach to four enantiomerically pure 2-naphthylmethyl 3-hydroxy-2-methylbutanoates, Tetrahedron, 64, 5551, 10.1016/j.tet.2008.03.088
Katrib, 1983, Synthesis and Xray photoelectron spectra of some azines, J. Chem. Eng. Data, 28, 132, 10.1021/je00031a035
Forbes, 1960, The synthesis of 1-, 2- and 3-trifluoromethylcarbazoles by the fischer-indole method, Tetrahedron, 8, 67, 10.1016/S0040-4020(01)93332-0